April 12, 2017
Kadmon Announces Publication of Clinical Data Showing KD025 Improved Clinical Scores in Psoriasis Patients
April 04, 2017
Kadmon Submits Second Abbreviated New Drug Application Filing for Trientine Hydrochloride to FDA
April 03, 2017
Kadmon Announces Amendment to Credit Agreement and Related Warrants
View and download our company filings.
View our latest investor presentations, webcasts and events calendar.
We are committed to maintaining ongoing, open dialogue with the investor community. Explore financial news, investor events, press releases and contact information here.
Learn more about investing in our growth.
Receive press releases, SEC filings and more.
Subscribe to alerts
Kadmon Corporation, LLC
Copyright 2017. All Rights Reserved.